[Seminar] Latest Trends in Research and Development Policies for the Creation of Innovative Pharmaceuticals
Ministry of Health, Labour and Welfare - Efforts to Strengthen Research and Development Infrastructure, Promote Industry-Academia-Government Collaboration, and Create Innovation.
Our company will hold a business seminar. 【Practical Insights Gained from the Seminar】 - Policy trends aimed at strengthening drug discovery capabilities and eliminating drug loss - Directions for building a drug discovery ecosystem and promoting clinical trials - Research and development policies surrounding regenerative medicine and genomic medicine - Initiatives and future developments towards drug discovery and medical AX - Directions for the research and development infrastructure supporting the creation of innovative pharmaceuticals 【Target Industries and Departments】 - Pharmaceuticals / Biotech / Regenerative Medicine / Drug Discovery Startups - CROs / SMOs / Medical Institutions / Clinical Trial and Development-related Businesses - AI / Data / Digital Health / Medical DX-related Companies - Trading Companies / Finance / Investment / Healthcare New Business-related Companies - Corporate Planning / Research and Development / Business Development / Clinical Development / Regulatory Affairs Departments 【Seminar Details】 ■ Date and Time: November 26, 2026 (Thursday) 09:30 - 11:30 (Doors open at 9:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Speaker: Ministry of Health, Labour and Welfare Director of Research and Development Policy, Medical Affairs Bureau Mr. Kei Mori *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
**Lecture Overview** In our country, efforts are being made to address the issue of pharmaceuticals (drug loss) that, despite being approved in Europe and the United States, have not been developed domestically. We are also advancing discussions aimed at strengthening drug discovery capabilities and building a social system that sustains a cycle of investment and innovation creation. In this context, recent years have seen advancements in research and development of genomic medicine and regenerative medicine, as well as rapid technological progress in artificial intelligence (AI). Various initiatives are being undertaken to utilize these new technologies, establish a foundation for research and safe provision of advanced medical technologies, and we will detail recent trends in research and development policies aimed at the creation of innovative pharmaceuticals. **Lecture Topics** ■ Efforts toward building a drug discovery ecosystem and promoting clinical trials ■ Efforts to promote regenerative medicine ■ Efforts to promote genomic medicine ■ Efforts to promote drug discovery and medical AX ■ Related Q&A ■ Business card exchange and networking event (for on-site participants only)
Price information
【Participation Fee】 1 person: 37,960 yen (including tax) Special Offer: One additional person from the same organization can attend for free (limited to in-person or live streaming) (Please register both participants simultaneously with the same participation format at the time of application. Additional registrations after one person has been applied for are not eligible.) Special Offer: For those affiliated with local public organizations, up to two people can attend for 11,000 yen (including tax, limited to in-person or live streaming with the same participation format for both).
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
